Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

NCT03541928 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

High-risk Prostate Cancer
Prostate Cancer

Interventions

DRUG: HSV-Tk
DRUG: Valacyclovir
DRUG: Bicalutamide
DRUG: Leuprolide Acetate
RADIATION: Brachytherapy, External beam radiotherapy
PROCEDURE: Radical prostatectomy

Sponsor

The Methodist Hospital Research Institute